IPP Bureau
Quantumzyme receives patent for development of green catalyst in India
By IPP Bureau - March 25, 2023
The patent was granted for creating a green catalyst for one of the world's most significant chemical reactions
Zydus receives final approval from USFDA for Doxepin Hydrochloride Capsules USP, 150 mg
By IPP Bureau - March 25, 2023
Doxepin Hydrochloride capsule is indicated to treat mental/mood problems such as depression and anxiety
Zydus receives final approval from USFDA for Lubiprostone Capsules, 8 mcg and 24 mcg
By IPP Bureau - March 25, 2023
Lubiprostone capsule is indicated to treat certain types of constipation (chronic idiopathic constipation and irritable bowel syndrome with constipation)
Lupin receives tentative approval from USFDA for Obeticholic Acid Tablets
By IPP Bureau - March 24, 2023
Obeticholic Acid Tablets (RLD Ocaliva) had estimated annual sales of US $255 million in the US (IQVIA MAT December 2022).
hubergroup India expands its support for rural healthcare
By IPP Bureau - March 24, 2023
hubergroup’s two newly added medical vans are dedicated to dental and eye care
PM chairs high-level meeting to asses situation of Covid-19 & Influenza
By IPP Bureau - March 23, 2023
PM emphasises the need to enhance lab surveillance & testing of all Severe Acute Respiratory Illness (SARI) cases & ramp up genome sequencing
PM to address One World TB Summit tomorrow
By IPP Bureau - March 23, 2023
PM to launch TB-Mukt Panchayat initiative; official pan-India rollout of a shorter TB Preventive Treatment and Family-centric care model for TB
Emmes acquires Essex Management
By IPP Bureau - March 23, 2023
Essex enriches and complements Emmes’ services
Medanta launches women and child care services in Gurugram
By IPP Bureau - March 23, 2023
Women of all ages will get round-the-clock access to comprehensive treatment
Investment in healthcare workforce key to accelerating India’s economic growth: Experts
By IPP Bureau - March 23, 2023
Integration of modern and traditional medicine to facilitate the illness to wellness journey
OPPI launches ‘Bharat Ke Liye’ to reinforce commitment to improve health outcomes
By IPP Bureau - March 23, 2023
This initiative encapsulates the essence of OPPI’s commitment towards enabling a healthier India
FedEx Express to showcase healthcare solutions at Indian Biologics Festival 2023
By IPP Bureau - March 23, 2023
FedEx will be displaying a wide-range of effective healthcare packaging and specialized tracking technology
Osteoarthritis candidate MM-II showed durable pain relief in Global Phase 2b study
By IPP Bureau - March 23, 2023
The data from this study show that MM-II has the potential to provide durable pain relief for our patients
Zydus receives final and tentative approval from USFDA for Tofacitinib Tablets
By IPP Bureau - March 22, 2023
Tofacitinib Tablets, 5 mg and 10 mg had annual sales of US $900 million in the United States (IQVIA MAT December 2022)
Granules Consumer Health concludes FDA audit with zero observations
By IPP Bureau - March 22, 2023
The audit is a pre-approval inspection for three products filed from the facility
